These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21972727)

  • 21. Antioxidant and anti-inflammatory effects of a hypoglycemic fraction from Cucurbita ficifolia Bouché in streptozotocin-induced diabetes mice.
    Roman-Ramos R; Almanza-Perez JC; Fortis-Barrera A; Angeles-Mejia S; Banderas-Dorantes TR; Zamilpa-Alvarez A; Diaz-Flores M; Jasso I; Blancas-Flores G; Gomez J; Alarcon-Aguilar FJ
    Am J Chin Med; 2012; 40(1):97-110. PubMed ID: 22298451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-15 that a regulator of TNF-α in patients with diabetes mellitus type 2.
    Sánchez-Jiménez R; Alvarado-Vásquez N
    Med Hypotheses; 2013 Jun; 80(6):776-7. PubMed ID: 23566659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats.
    Ahad A; Ganai AA; Mujeeb M; Siddiqui WA
    Toxicol Appl Pharmacol; 2014 Aug; 279(1):1-7. PubMed ID: 24848621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-inflammatory properties of bone morphogenetic protein 4 in human adipocytes.
    Baraban E; Chavakis T; Hamilton BS; Sales S; Wabitsch M; Bornstein SR; Ehrhart-Bornstein M
    Int J Obes (Lond); 2016 Feb; 40(2):319-27. PubMed ID: 26228459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?
    Rehman K; Akash MS
    J Biomed Sci; 2016 Dec; 23(1):87. PubMed ID: 27912756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple benefits of targeting inflammation in the treatment of type 2 diabetes.
    Donath MY
    Diabetologia; 2016 Apr; 59(4):679-82. PubMed ID: 26868493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tetrapleura tetraptera spice attenuates high-carbohydrate, high-fat diet-induced obese and type 2 diabetic rats with metabolic syndrome features.
    Kuate D; Kengne AP; Biapa CP; Azantsa BG; Abdul Manan Bin Wan Muda W
    Lipids Health Dis; 2015 May; 14():50. PubMed ID: 26003803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effects of silibinin against the progression of metabolic syndrome, increased oxidative stress, and liver steatosis in Psammomys obesus, a relevant animal model of human obesity and diabetes.
    Bouderba S; Sanchez-Martin C; Villanueva GR; Detaille D; Koceïr EA
    J Diabetes; 2014 Mar; 6(2):184-92. PubMed ID: 23953934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of insulin to improve glycemic control in diabetes mellitus.
    Dandona P; Chaudhuri A; Ghanim H; Mohanty P
    Cardiovasc Drugs Ther; 2008 Jun; 22(3):241-51. PubMed ID: 18347965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Taurin in combined treatment of metabolic syndrome and diabetes mellitus].
    Ter Arkh; 2011; 83(10):31-6. PubMed ID: 22185022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
    Elmarakby AA; Sullivan JC
    Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control.
    Pedersen BK
    Essays Biochem; 2006; 42():105-17. PubMed ID: 17144883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance syndrome. Description, pathogenesis, and management.
    Miller JL
    Postgrad Med; 2003 May; Spec No():27-34. PubMed ID: 12785129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adipose tissue macrophages.
    Zeyda M; Stulnig TM
    Immunol Lett; 2007 Oct; 112(2):61-7. PubMed ID: 17719095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome: nature, therapeutic solutions and options.
    Onat A
    Expert Opin Pharmacother; 2011 Aug; 12(12):1887-1900. PubMed ID: 21756201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome.
    Devaraj S; Chan E; Jialal I
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4489-96. PubMed ID: 16968805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
    Tjokroprawiro A
    Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Possible Role of Flavonoids in the Prevention of Diabetic Complications.
    Testa R; Bonfigli AR; Genovese S; De Nigris V; Ceriello A
    Nutrients; 2016 May; 8(5):. PubMed ID: 27213445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.